Small noncoding vault RNA2-1 disrupts gut epithelial barrier function via interaction with HuR

EMBO Rep. 2023 Feb 6;24(2):e54925. doi: 10.15252/embr.202254925. Epub 2022 Nov 28.

Abstract

Vault RNAs (vtRNAs) are small noncoding RNAs and highly expressed in many eukaryotes. Here, we identified vtRNA2-1 as a novel regulator of the intestinal barrier via interaction with RNA-binding protein HuR. Intestinal mucosal tissues from patients with inflammatory bowel diseases and from mice with colitis or sepsis express increased levels of vtRNAs relative to controls. Ectopically expressed vtRNA2-1 decreases the levels of intercellular junction (IJ) proteins claudin 1, occludin, and E-cadherin and causes intestinal epithelial barrier dysfunction in vitro, whereas vtRNA2-1 silencing promotes barrier function. Increased vtRNA2-1 also decreases IJs in intestinal organoid, inhibits epithelial renewal, and causes Paneth cell defects ex vivo. Elevating the levels of tissue vtRNA2-1 in the intestinal mucosa increases the vulnerability of the gut barrier to septic stress in mice. vtRNA2-1 interacts with HuR and prevents HuR binding to claudin 1 and occludin mRNAs, thus decreasing their translation. These results indicate that vtRNA2-1 impairs intestinal barrier function by repressing HuR-facilitated translation of claudin 1 and occludin.

Keywords: RNA-binding proteins; gut permeability; mucosal defense; posttranscriptional regulation; vault RNAs.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Claudin-1 / genetics
  • Claudin-1 / metabolism
  • Colitis* / genetics
  • Colitis* / metabolism
  • Intestinal Mucosa / metabolism
  • Mice
  • MicroRNAs* / metabolism
  • Occludin / metabolism
  • Paneth Cells*

Substances

  • Claudin-1
  • Occludin
  • ELAVL1 protein, human
  • Elavl1 protein, mouse
  • MIRN886 microRNA, human
  • MicroRNAs